Recombinant Human B-lymphocyte antigen CD19 (CD19), partial , Active Protein
Recombinant Human B-lymphocyte antigen CD19 (CD19), partial , Active Protein is a purified Active Recombinant Protein. Purity: >95% as determined by SDS-PAGE. Host: Mammalian cell. Endotoxin Level: <1.0 EU/ug as determined by LAL method. Species: Human (Homo sapiens) . Target Name: B-lymphocyte antigen CD19 (CD19) . Accession Number: P15391; CD19. Expression Region: 20-291aa. Tag Info: C-terminal Fc-tagged. Theoretical MW: 57.3kda. Target Synonyms: B-Lymphocyte Antigen CD19; B-Lymphocyte Surface Antigen B4; Differentiation Antigen CD19; T-Cell Surface Antigen Leu-12; CD19 Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
Short Description
Recombinant Human B-lymphocyte antigen CD19 (CD19), partial , Active Protein is a purified Active Recombinant Protein.
Accession Number
P15391; CD19
Expression Region
20-291aa
Host
Mammalian Cells
Target
B-lymphocyte antigen CD19 (CD19)
Conjugation
Unconjugated
Tag
C-Terminal Fc-Tagged
Field of Research
Immunology
Endotoxin
<1.0 EU/ug, by LAL method
Purity
>95% by SDS-PAGE
Activity
Biologically Active
Length
Extracellular Domain
Reconstitution
Refer to the datasheet/CoA included in the product pouch.
Molecular Weight
57.3kDa
Shipping Conditions
Ice packs
Storage Conditions
-20°C. Avoid repeated freeze/thaw cycles.
Target Alternative Name
B-Lymphocyte Antigen CD19; B-Lymphocyte Surface Antigen B4; Differentiation Antigen CD19; T-Cell Surface Antigen Leu-12; CD19
Species
Human (Homo sapiens)
Protein Name
Active Recombinant Protein
AA Sequence
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items